题名 | Erlotinib alone or with bevacizumab as first-line therapy in patients with advanced non-squamous non-small-cell lung cancer harbouring EGFR mutations (JO25567): an open-label, randomised, multicentre, phase 2 study |
链接 | http://www.sciencedirect.com/science/article/pii/S147020451470381X |
欢迎光临 科研速递论坛 (http://expaper.cn/) | Powered by Discuz! X2.5 |